BSEVivanza Biosciences LtdMediumNegative
Announced Tue, 17 Mar · 15:29 IST

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding intimation of Resignation of Mr. Hemant Amrish Parikh as Non-Executive Director with Effect from 17/03/2026

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹1.90
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.5-4.2-4.2-2.6-7.4+7.4+8.9-3.7-6.8
Up moveDown movePending
AI summary

Vivanza Biosciences Ltd has informed the stock exchange that Mr. Hemant Amrish Parikh (DIN: 00027820) has resigned from the post of Non-Executive Director with effect from the close of business hours on March 17, 2026. The reason cited is personal reasons, and the director has confirmed there are no other material reasons behind the exit. The company has attached his resignation letter as Annexure B and the required SEBI disclosure details as Annexure A. The communication has been signed by Jayendra Mehta, Managing Director of the company.

Likely market impact

This is a routine board-level change involving a Non-Executive Director leaving for personal reasons, with no governance concerns flagged. The exit is unlikely to have any material impact on the company's operations or stock price, though shareholders may want to watch whether a replacement director is appointed in due course.